Note 17: Segment Reporting

 

The Company has two reportable operating segments based on two primary areas of service. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and the impact on both human health and the environment.

Segment information is presented for selected data from the statements of income and statements of cash flows for 2025, 2024 and 2023. Segment information for selected data from the balance sheets is presented for the fiscal years ended January 2, 2026 and January 3, 2025. The Company’s CEO, the chief operating decision maker, does not review total assets in her evaluation of segment performance and capital allocation.

Revenues

 

 

Fiscal Years

 

(In thousands)

 

2025

 

 

2024

 

 

2023

 

Engineering and Other Scientific

 

$

493,893

 

 

$

469,544

 

 

$

446,888

 

Environmental and Health

 

 

88,121

 

 

 

88,970

 

 

 

89,878

 

Total revenues

 

$

582,014

 

 

$

558,514

 

 

$

536,766

 

 

Compensation and related expenses

 

 

Fiscal Years

 

(In thousands)

 

2025

 

 

2024

 

 

2023

 

Engineering and Other Scientific

 

$

230,326

 

 

$

223,395

 

 

$

215,650

 

Environmental and Health

 

 

47,767

 

 

 

47,600

 

 

 

48,619

 

 

 

 

 

 

 

 

 

 

Total segment compensation and related expenses

 

 

278,093

 

 

 

270,995

 

 

 

264,269

 

 

 

 

 

 

 

 

 

 

Corporate compensation and related expenses

 

 

63,901

 

 

 

59,016

 

 

 

55,617

 

Total compensation and related expenses

 

$

341,994

 

 

$

330,011

 

 

$

319,886

 

 

Certain expenses are excluded from the Company’s measure of segment compensation and related expenses. These include the deferred compensation expense/benefit due to changes in value of assets associated with the Company’s deferred compensation plan; stock-based compensation associated with restricted stock unit and stock option awards, and the compensation costs associated with the Company’s human resources, finance, information technology, corporate, and business development groups.

 

Operating Income

 

 

Fiscal Years

 

(In thousands)

 

2025

 

 

2024

 

 

2023

 

Engineering and Other Scientific

 

$

173,625

 

 

$

164,883

 

 

$

153,918

 

Environmental and Health

 

 

30,558

 

 

 

29,995

 

 

 

28,432

 

 

 

 

 

 

 

 

 

 

Total segment operating income

 

 

204,183

 

 

 

194,878

 

 

 

182,350

 

 

 

 

 

 

 

 

 

 

Corporate operating expense

 

 

(84,396

)

 

 

(75,321

)

 

 

(71,028

)

Total operating income

 

$

119,787

 

 

$

119,557

 

 

$

111,322

 

 

Certain operating expenses are excluded from the Company's measure of segment operating income. These expenses include the costs associated with the Company’s human resources, finance, information technology, corporate, and business development groups; the deferred compensation expense/benefit due to the change in value of assets associated with the Company’s deferred compensation plan; stock-based compensation associated with restricted stock unit and stock option awards; and the change in the Company’s allowance for contract losses and doubtful accounts.

 

Capital Expenditures

 

 

Fiscal Years

 

(In thousands)

 

2025

 

 

2024

 

 

2023

 

Engineering and Other Scientific

 

$

5,341

 

 

$

3,257

 

 

$

3,895

 

Environmental and Health

 

 

238

 

 

 

77

 

 

 

170

 

 

 

 

 

 

 

 

 

 

Total segment capital expenditures

 

 

5,579

 

 

 

3,334

 

 

 

4,065

 

 

 

 

 

 

 

 

 

 

Corporate capital expenditures

 

 

3,478

 

 

 

4,043

 

 

 

14,630

 

Total capital expenditures

 

$

9,057

 

 

$

7,377

 

 

$

18,695

 

 

Certain capital expenditures associated with the Company's corporate cost centers and the related depreciation are excluded from the Company's segment information.

 

Depreciation and Amortization

 

 

Fiscal Years

 

(In thousands)

 

2025

 

 

2024

 

 

2023

 

Engineering and Other Scientific

 

$

7,344

 

 

$

6,833

 

 

$

6,087

 

Environmental and Health

 

 

201

 

 

 

206

 

 

 

213

 

 

 

 

 

 

 

 

 

 

Total segment depreciation and amortization

 

 

7,545

 

 

 

7,039

 

 

 

6,300

 

 

 

 

 

 

 

 

 

 

Corporate depreciation and amortization

 

 

2,538

 

 

 

2,650

 

 

 

2,616

 

Total depreciation and amortization

 

$

10,083

 

 

$

9,689

 

 

$

8,916

 

 

Information regarding the Company’s operations in different geographical areas:

Property, Equipment and Leasehold Improvements, net

 

 

Fiscal Years

 

(In thousands)

 

2025

 

 

2024

 

United States

 

$

71,135

 

 

$

72,418

 

Foreign Countries

 

 

846

 

 

 

589

 

Total

 

$

71,981

 

 

$

73,007

 

 

Revenues (1)

 

 

Fiscal Years

 

(In thousands)

 

2025

 

 

2024

 

 

2023

 

United States

 

$

520,591

 

 

$

493,067

 

 

$

470,078

 

Foreign Countries

 

 

61,423

 

 

 

65,447

 

 

 

66,688

 

Total

 

$

582,014

 

 

$

558,514

 

 

$

536,766

 

 

(1)
Geographic revenues are allocated based on the location of the client.

Below is a breakdown of goodwill, reported by segment as of January 2, 2026 and January 3, 2025:

(In thousands)

 

Environmental
and Health

 

 

Engineering
and Other
Scientific

 

 

Total

 

Goodwill

 

$

8,099

 

 

$

508

 

 

$

8,607

 

 

There were no changes in the carrying amount of goodwill for 2025, 2024 and 2023. There were no goodwill impairments or gains or losses on disposals for any portion of the Company’s reporting units during 2025, 2024, and 2023.

Historical Timeline

Fiscal YearFiled
2026Feb 27, 2026Showing above
2025Feb 28, 2025
2023Feb 23, 2024
2022Feb 24, 2023
2021Feb 25, 2022
2020Feb 28, 2020
2018Feb 22, 2019
2017Feb 23, 2018
2016Feb 24, 2017

About Segments Disclosures

Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.

Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.